Total Payments
$71,975
2022 Payments
$19,777
Companies
42
Transactions
1,080
Medicare Patients
1,214
Medicare Billing
$451,873
Payment Breakdown by Category
Other$42,060 (58.4%)
Food & Beverage$22,558 (31.3%)
Travel$5,828 (8.1%)
Consulting$1,000 (1.4%)
Education$529.18 (0.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $42,060 | 24 | 58.4% |
| Food and Beverage | $22,558 | 997 | 31.3% |
| Travel and Lodging | $5,828 | 42 | 8.1% |
| Consulting Fee | $1,000 | 1 | 1.4% |
| Education | $529.18 | 16 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $28,239 | 137 | $0 (2022) |
| Ironshore Pharmaceuticals Inc. | $24,184 | 89 | $0 (2022) |
| Takeda Pharmaceuticals U.S.A., Inc. | $1,981 | 100 | $0 (2022) |
| Lundbeck LLC | $1,929 | 112 | $0 (2022) |
| Otsuka America Pharmaceutical, Inc. | $1,889 | 107 | $0 (2022) |
| Sunovion Pharmaceuticals Inc. | $1,650 | 98 | $0 (2022) |
| Neurocrine Biosciences, Inc. | $1,631 | 74 | $0 (2022) |
| Teva Pharmaceuticals USA, Inc. | $1,575 | 62 | $0 (2022) |
| Brainsway USA INC | $1,318 | 7 | $0 (2021) |
| Neuronetics, Inc. | $1,109 | 10 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $19,777 | 165 | Janssen Pharmaceuticals, Inc ($16,641) |
| 2021 | $7,077 | 210 | Ironshore Pharmaceuticals Inc. ($2,688) |
| 2020 | $13,138 | 156 | Ironshore Pharmaceuticals Inc. ($7,634) |
| 2019 | $26,385 | 297 | Ironshore Pharmaceuticals Inc. ($13,837) |
| 2018 | $3,399 | 162 | Teva Pharmaceuticals USA, Inc. ($564.07) |
| 2017 | $2,199 | 90 | Otsuka America Pharmaceutical, Inc. ($519.13) |
All Payment Transactions
1,080 individual payment records from CMS Open Payments — Page 1 of 44
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/20/2022 | Bausch Health US, LLC | WELLBUTRIN (Drug), APLENZIN | Food and Beverage | In-kind items and services | $20.07 | General |
| Category: Neurology | ||||||
| 10/17/2022 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,340.00 | General |
| Category: Neuroscience | ||||||
| 10/12/2022 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Travel and Lodging | Cash or cash equivalent | $191.39 | General |
| Category: Neuroscience | ||||||
| 10/12/2022 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Travel and Lodging | Cash or cash equivalent | $76.00 | General |
| Category: Neuroscience | ||||||
| 10/12/2022 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Travel and Lodging | Cash or cash equivalent | $48.52 | General |
| Category: Neuroscience | ||||||
| 10/12/2022 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | Cash or cash equivalent | $33.27 | General |
| Category: Neuroscience | ||||||
| 10/12/2022 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | Cash or cash equivalent | $29.00 | General |
| Category: Neuroscience | ||||||
| 10/12/2022 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Travel and Lodging | Cash or cash equivalent | $25.00 | General |
| Category: Neuroscience | ||||||
| 10/12/2022 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | Cash or cash equivalent | $22.27 | General |
| Category: Neuroscience | ||||||
| 10/12/2022 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | Cash or cash equivalent | $18.31 | General |
| Category: Neuroscience | ||||||
| 10/12/2022 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | Cash or cash equivalent | $15.00 | General |
| Category: Neuroscience | ||||||
| 10/12/2022 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | Cash or cash equivalent | $11.50 | General |
| Category: Neuroscience | ||||||
| 10/12/2022 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | Cash or cash equivalent | $5.00 | General |
| Category: Neuroscience | ||||||
| 10/10/2022 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Travel and Lodging | Cash or cash equivalent | $96.16 | General |
| Category: Neuroscience | ||||||
| 10/10/2022 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Travel and Lodging | Cash or cash equivalent | $43.80 | General |
| Category: Neuroscience | ||||||
| 10/10/2022 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Travel and Lodging | Cash or cash equivalent | $20.00 | General |
| Category: Neuroscience | ||||||
| 10/06/2022 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,730.00 | General |
| Category: Neuroscience | ||||||
| 09/29/2022 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Travel and Lodging | In-kind items and services | $255.94 | General |
| Category: Neuroscience | ||||||
| 09/29/2022 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Travel and Lodging | Cash or cash equivalent | $60.00 | General |
| Category: Neuroscience | ||||||
| 09/26/2022 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Travel and Lodging | Cash or cash equivalent | $78.13 | General |
| Category: Neuroscience | ||||||
| 09/26/2022 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | Cash or cash equivalent | $17.70 | General |
| Category: Neuroscience | ||||||
| 09/22/2022 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,340.00 | General |
| Category: Neuroscience | ||||||
| 09/19/2022 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,340.00 | General |
| Category: Neuroscience | ||||||
| 09/16/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $22.25 | General |
| Category: NEUROSCIENCE | ||||||
| 09/15/2022 | Bausch Health US, LLC | WELLBUTRIN (Drug), APLENZIN | Food and Beverage | In-kind items and services | $24.15 | General |
| Category: Neurology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 8 | 419 | 1,819 | $607,287 | $151,632 |
| 2021 | 7 | 425 | 1,803 | $546,611 | $156,864 |
| 2020 | 8 | 370 | 1,701 | $440,781 | $143,376 |
Total Patients
1,214
Total Services
5,323
Medicare Billing
$451,873
Procedure Codes
23
All Medicare Procedures & Services
23 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90868 | Treatment using magnetic field to stimulate nerve cells in brain, subsequent delivery and management | Office | 2022 | 32 | 807 | $403,500 | $81,085 | 20.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 131 | 398 | $73,630 | $22,082 | 30.0% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2022 | 126 | 358 | $38,502 | $17,517 | 45.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 16 | 72 | $25,920 | $11,257 | 43.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 39 | 78 | $21,060 | $7,586 | 36.0% |
| 90867 | Treatment using magnetic field to stimulate nerve cells in brain, initial delivery and management | Office | 2022 | 24 | 25 | $21,250 | $4,204 | 19.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 28 | 28 | $16,800 | $4,170 | 24.8% |
| 90836 | Psychotherapy with evaluation and management visit, 45 minutes | Office | 2022 | 23 | 53 | $6,625 | $3,731 | 56.3% |
| 90868 | Transcranial magnetic stimulation treatment (stimulates nerve cells in brain to improve symptoms of depression), subsequent delivery and management, per session | Office | 2021 | 31 | 766 | $381,425 | $82,988 | 21.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 130 | 440 | $69,698 | $30,326 | 43.5% |
| 90833 | Psychotherapy performed with evaluation and management visit, 30 minutes | Office | 2021 | 127 | 396 | $38,754 | $21,251 | 54.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 60 | 105 | $22,823 | $10,940 | 47.9% |
| 90867 | Transcranial magnetic stimulation treatment (stimulates nerve cells in brain to improve symptoms of depression), initial delivery and management | Office | 2021 | 22 | 25 | $20,600 | $4,760 | 23.1% |
| 90836 | Psychotherapy with evaluation and management visit, 45 minutes | Office | 2021 | 34 | 50 | $5,125 | $3,601 | 70.3% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2021 | 21 | 21 | $8,186 | $2,998 | 36.6% |
| 90868 | Transcranial magnetic stimulation treatment (stimulates nerve cells in brain to improve symptoms of depression), per session | Office | 2020 | 23 | 615 | $306,205 | $64,943 | 21.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 104 | 383 | $37,838 | $23,489 | 62.1% |
| 90833 | Psychotherapy, 30 minutes | Office | 2020 | 105 | 379 | $32,448 | $21,726 | 67.0% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 16 | 121 | $23,013 | $14,827 | 64.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 44 | 87 | $12,407 | $7,408 | 59.7% |
| 90836 | Psychotherapy, 45 minutes | Office | 2020 | 43 | 81 | $8,773 | $5,800 | 66.1% |
| 90867 | Transcranial magnetic stimulation treatment (stimulates nerve cells in brain to improve symptoms of depression) | Office | 2020 | 19 | 19 | $15,411 | $3,352 | 21.8% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2020 | 16 | 16 | $4,685 | $1,832 | 39.1% |
About Dr. Saad Shakir, M.D
Dr. Saad Shakir, M.D is a Psychiatry healthcare provider based in San Jose, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/27/2007. The National Provider Identifier (NPI) number assigned to this provider is 1245367374.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Saad Shakir, M.D has received a total of $71,975 in payments from pharmaceutical and medical device companies, with $19,777 received in 2022. These payments were reported across 1,080 transactions from 42 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($42,060).
As a Medicare-enrolled provider, Shakir has provided services to 1,214 Medicare beneficiaries, totaling 5,323 services with total Medicare billing of $451,873. Data is available for 3 years (2020–2022), covering 23 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Location San Jose, CA
- Active Since 02/27/2007
- Last Updated 09/23/2016
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1245367374
Products in Payments
- SPRAVATO (Drug) $27,304
- Jornay PM 20mg capsules (Bottle of 100) (Drug) $13,837
- JORNAY PM (Drug) $10,347
- REXULTI (Drug) $2,493
- LATUDA (Drug) $1,650
- INGREZZA (Drug) $1,608
- TRINTELLIX (Drug) $1,513
- BrainsWay Deep TMS (Device) $1,075
- INVEGA SUSTENNA (Drug) $934.88
- AUSTEDO (Drug) $893.66
- CAPLYTA (Drug) $881.16
- NEUROSTAR TMS THERAPY SYSTEM (Device) $770.15
- Trintellix (Drug) $752.57
- ABILIFY MAINTENA (Drug) $710.67
- VYVANSE (Drug) $557.92
- VRAYLAR (Drug) $475.91
- Fanapt (Drug) $451.71
- NUEDEXTA (Drug) $438.36
- SUBLOCADE (Drug) $328.46
- FANAPT (Drug) $315.33
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in San Jose
Danh Huynh, Md, MD
Psychiatry — Payments: $9,201
Psychiatry $9,201
Dr. Nhi Huynh, M.d, M.D
Psychiatry — Payments: $9,026
Psychiatry $9,026
Ali Alkoraishi, M.d, M.D
Psychiatry — Payments: $5,693
Psychiatry $5,693
Dr. Hector Cerezo, M.d., Inc, M.D., INC
Psychiatry — Payments: $5,221
Psychiatry $5,221
Dr. Phuong-Thuy Le, Md, MD
Psychiatry — Payments: $5,010
Psychiatry $5,010
Dr. Michael Quach, M.d, M.D
Psychiatry — Payments: $4,393
Psychiatry $4,393